Q4 2020 Holdings
Filed 2021-02-16 | 13 holdings | $120.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| ALX Oncology Holdings Inc.(ALXO) | COM | 00166B105 | $83.9M | 973,514 | 69.5% |
| Cytokinetics Incorporated(CYTK) | COM | 23282W605 | $29.8M | 1,435,992 | 24.7% |
| Aclaris Therapeutics, Inc.(ACRS) | COM | 00461U105 | $6.2M | 951,384 | 5.1% |
| Kinnate Biopharma Inc. | COM | 49705R105 | $384.7K | 9,671,643 | 0.3% |
| Keros Therapeutics, Inc.(KROS) | COM | 492327101 | $99.7K | 1,412,705 | 0.1% |
| Relay Therapeutics, Inc.(RLAY) | COM | 75943R102 | $88.9K | 2,139,380 | 0.1% |
| Nurix Therapeutics, Inc.(NRIX) | COM | 67080M103 | $77.2K | 2,347,804 | 0.1% |
| Kura Oncology, Inc.(KURA) | COM | 50127T109 | $59.0K | 1,807,982 | 0.0% |
| Olema Pharmaceuticals, Inc.(OLMA) | COM | 68062P106 | $39.3K | 818,030 | 0.0% |
| Generation Bio Co.(GBIOGBX) | COM | 37148K100 | $24.3K | 857,939 | 0.0% |
| Vaxcyte, Inc.(PCVX) | COM | 92243G108 | $12.4K | 465,821 | 0.0% |
| Cymabay Therapeutics, Inc.(CBAYUSD) | COM | 23257D103 | $10.3K | 1,787,094 | 0.0% |
| Therapeutics Acquisition Corp | COM CL A | 88339T103 | $4.9K | 350,000 | 0.0% |